Pauls Dietrich John 4
4 · DiaMedica Therapeutics Inc. · Filed Jul 29, 2021
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2021-07-28+175,000→ 175,000 totalExercise: $5.00Exp: 2031-07-27→ Common Shares (175,000 underlying)
Holdings
- 30,804
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- [F2]Vests in sixteen nearly equal quarterly installments over four years.